Skip to main content
. 2021 Dec 30;1253:132308. doi: 10.1016/j.molstruc.2021.132308

Table 5.

DPPH free radical scavenging activity of ligand acids and synthesized complexes.

Compound % Inhibition
Dose Conc. (µM)
15 30 60 120 240
HL1 8.74 ± 1.45 12.3 ± 1.67 23.4 ± 2.02 38.12 ± 2.11 43.00 ± 1.34
HL2 4.65 ± .04 7.41 ± 1.02 13.02 ± 1.32 19.76 ± 1.58 27.06 ± 2.21
1 17.34 ± 1.21 20.45 ± 2.10 49.76 ± 2.68 67.76 ± 2.97 78.56 ± 2.38
2 5.39 ± .68 8.10 ± 0.86 18.29 ± 1.42 26.7 ± 1.32 36.09 ± 2.13
Vit C 15.00 ± 1.34 32.88 ± 2.65 49.00 ± 1.89 72.00 ± 2.55 92.00 ± 1.91
HHS Vulnerability Disclosure